[Takuro NIIDOME]

1. Wei Xu, Anna Kawano, Tatsuya Baba, Takuro Niidome, Antibacterial and Antiviral Activity of Graphene Quantum Dots, 8th Asian Biomaterial Conference, 2021/11/28, Nagoya, Japan
2. Takuro Niidome, Emi Takeda, Mitsuhiro Terakawa, Control of Antibacterial Activity of Silica-Coated Silver Nanoplates by Light, 8th Asian Biomaterial Conference, 2021/11/28, Nagoya, Japan
3. Takuro Niidome, Gold nanorods for DDS, silver nanoplates as an antimicrobial agent, and magnesium alloy for bioresorbable medical devices, Special Seminar in Department of Chemical Engineering, Kyrgyz-Turkish Manas University, 2021/11/18, web
4. Takuro Niidome, Gold, Silver, and Magnesium as Medical Materials, BK21 seminar in Department of Biomedical Engineering in Yonsei University, 2021/10/8, web
5. Xiao, W. Xu, Y. Komohara, Y. Fujiwara, H. Hirose, S. Futaki, T. Niidome, Effect of surface modifications on cellular uptake of gold nanorods in human primary cells and established cell lines, ACS Omega, 5, 32744-32752 (2020)
6. Ueno, M. W. Kim, G. Lee, Y. I. Park, T. Niidome, R. Lee, Development of ErbB2-targeting liposomes for enhancing drug delivery to ErbB2-positive breast cancer, Pharmaceutics, 12, 585 (2020)
7. Taharabaru, R. Yokoyama, T. Higashi, A. F. A. Mohammed, M. Inoue, Y. Maeda, T. Niidome, R. Onodera, K. Motoyama, Genome editing in a wide area of brain using dendrimer-based ternary polyplex of Cas9 ribonucleoprotein, ACS Appl. Mater. Interfaces, 12, 21386–21397 (2020)
8. Tsutsuki, T. Zhang, A. Harada, A. Rahman, K. Ono, K. Yahiro, T. Niidome, T. Sawa, Involvement of protein disulfide isomerase in Subtilase cytotoxin-induced cell death in HeLa cells, Biochem. Biophys. Res. Co., 525, 1068-1073 (2020)
9. W. Kim, G. Lee, T. Niidome, Y. Komohara, R. Lee, Y. I. Park, Platelet-like gold nanostars for cancer therapy: the ability to treat cancer and evade immune reactions, Front. Bioeng. Biotechnol., 8, 133 (2020)
10. Harada, H. Tsutsuki, T. Zhang, R. Lee, K. Yahiro, T. Sawa, T. Niidome, Preparation of biodegradable PLGA-nanoparticles used for pH-sensitive intracellular delivery of an anti-inflammatory bacterial toxin to macrophages, Chem. Pharm. Bull., 68, 363–368 (2020)
11. Xu, K. Yagoshi, T. Asakura, M. Sasaki, T. Niidome, Silk fibroin as a coating polymer for sirolimus-eluting magnesium alloy stents, ACS Applied Bio Materials, 3, 531-538 (2020)
12. Xu, K. Sato, Y. Koga, M. Sasaki, T. Niidome, Corrosion resistance of HF-treated Mg alloy stent following balloon expansion and its improvement through biodegradable polymer coating, J. Coat. Technol. Res. 17, 1023-1032 (2020)

[Ruda Lee]

1. Chinmaya Mahapatra, Ruda Lee, Manash K. Paul. Emerging role and promise of nanomaterials in organoid research. Drug discovery today, 27, 890-899, March 2022.
2. Kang Pa Lee, Suji Baek, Myeong Sik Yoon, Ji Soo Park, Bok Sil Hong, Sang Ju Lee, Seung Jun Oh, Seung Hae Kwon, Ruda Lee, Dae Ho Lee, Kang-Seo Park, Byung Seok Moon. Potential anticancer effect of aspirin and 2'‑hydroxy‑2,3,5'‑trimethoxychalcone‑linked polymeric micelles against cervical cancer through apoptosis. Oncology Letters, 23, 31, November 2021.
3. Sajid Fazal, Ruda Lee*. Biomimetic Bacterial Membrane Vesicles for Drug Delivery Applications. Pharmaceutics, 13, 1430, September 2021.
4. Yong Il Park, Seung-Hae Kwon, Gibok Lee, Keiichi Motoyama, Min Woo Kim, Min Lin, Takuro Niidome, Jung Hoon Choi, Ruda Lee*. pH-sensitive multi-drug liposomes targeting folate receptor β for efficient treatment of non-small cell lung cancer.Journal of Controlled Release, 330, 1-14, February 2021.
5. Sho Ueno, Min Woo Kim, Gibok Lee, Yong Il Park, Takuro Niidome, and Ruda Lee*. Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics, 12, 585, June 2020.
6. Song Yeul Lee*, Ruda Lee*, Eunha Kim, Sanghee Lee and Yong Il Park. Near-Infrared Light-Triggered Photodynamic Therapy and Apoptosis Using Upconversion Nanoparticles with Dual Photosensitizers. Frontiers in Bioengineering and Biotechnology, 8, 275. Apr 2020.
7. Seung-Hae Kwon, Taemin Wi, Yong Il Park, Min Woo Kim, Gibok Lee, Takumi Higaki, Jung Hoon Choi*, and Ruda Lee*. Noninvasive Early Detection of Calpain 2 Enriched Non-Small Cell Lung Cancer Using a Human Serum Albumin-Bounded Calpain 2 Nanosensor. Bioconjugate Chemistry, 31, 3, 803-812, Mar 2020.
8. Min Woo Kim, Gibok Lee, Takuro Niidome, Yoshihiro Komohara, Ruda Lee* and Yong Il Park*. Platelet-Like Gold Nanostars for Cancer Therapy: The Ability to Treat Cancer and Evade Immune Reactions. Frontiers in Bioengineering and Biotechnology, 8, 133. Feb 2020.
9. Sofiane Hamidi, Yukiko Nakaya, Hiroki Nagai, Cantas Alev, Takeya Kasukawa, Sapna Chhabra, Ruda Lee, Hitoshi Niwa, Aryeh Warmflash, Tatsuo Shibata, Guojun Sheng. Mesenchymal-epithelial transition regulates initiation of pluripotency exit before gastrulation. Development, 147, dev184960. Feb 2020.
10. Ruda Lee, Yu Jin Choi, Myeong Seon Jeong, Yong Il Park, Keiichi Motoyama, Min Woo Kim, Seung-Hae Kwon*, and Jung Hoon Choi*. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer. Bioconjugate Chemistry, 31, 3, 923-932, Feb 2020.
11. Ayaka Harada, Hiroyasu Tsutsuki, Tianli Zhang,Ruda Lee, Kinnosuke Yahiro, Tomohiro Sawa, Takuro Niidome, Preparation of biodegradable PLGA-nanoparticles used for pH-sensitive intracellular delivery of an anti-inflammatory bacterial toxin to macrophages. Chemical and Pharmaceutical Bulletin, 68, 4, 363-368, Jan 2020.

[Ick Chan KWON]

1. PDL1-binding peptide/anti-miRNA21 conjugate as a therapeutic modality for PD-L1high tumors and TAMs. Eun Hye Kim, Jongwon Lee, Gijung Kwak, Hochung Jang, Hyosuk Kim, Haeun Cho, Yeongji Jang, Jiwoong Choi, Sung-Gil Chi, Kwangmeyung Kim, Ick Chan Kwon, Yoosoo Yang, Sun Hwa Kim. Journal of Controlled Release 2022, 345, 62-74.
2. Ultraefficient extracellular vesicle–guided direct reprogramming of fibroblasts into functional cardiomyocytes. Hyosuk Kim, Byeong-Wook Song, Soon-Jung Park, Seong Woo Choi, Hanbyeol Moon, Ki-Chul Hwang, Sun-Woong Kang, Sung-Hwan Moon, Yoosoo Yang, Ick Chan Kwon*, Sun Hwa Kim. Science advances 2022, 8, eabj6621.
3. Multi-targeting siRNA nanoparticles for simultaneous inhibition of PI3K and Rac1 in PTEN-deficient prostate cancer. Min Ju Kim, Hyosuk Kim, Xueliang Gao, Ju Hee Ryu, Yoosoo Yang, Ick Chan Kwon, Thomas M Roberts, Sun Hwa Kim. Journal of Industrial and Engineering Chemistry 2021, 99, 196-203.
4. Bioorthogonally surface‐edited extracellular vesicles based on metabolic glycoengineering for CD44‐mediated targeting of inflammatory diseases. Gyeong Taek Lim, Dong Gil You, Hwa Seung Han, Hansang Lee, Sol Shin, Byeong Hoon Oh, EK Pramod Kumar, Wooram Um, Chan Ho Kim, Seungsu Han, Sangho Lee, Seungho Lim, Hong Yeol Yoon, Kwangmeyung Kim, Ick Chan Kwon, Dong‐Gyu Jo, Yong Woo Cho, Jae Hyung Park. Journal of extracellular vesicles 2021, 10, e12077
5. Short‐term cessation of dabigatran causes a paradoxical prothrombotic state. Jiwon Kim, Hee Jeong Jang, Dawid Schellingerhout, Su‐Kyoung Lee, Ha Kim, Young Dae Kim, Kyung‐Yul Lee, Hye‐Yeon Choi, Han‐Jin Cho, Seong‐Soo Jang, Sangmin Jeon, Ick Chan Kwon, Kwangmeyung Kim, Wi‐Sun Ryu, Matthias Nahrendorf, Seungbum Choi, Dong‐Eog Kim. Annals of Neurology 2021, 89, 444-458
6. In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy. Woojun Kim, Hong Yeol Yoon, Seungho Lim, Patrick S Stayton, In-San Kim, Kwangmeyung Kim, Ick Chan Kwon*. Journal of Controlled Release 2021, 329, 223-236.
7. Intracellular uptake mechanism of bioorthogonally conjugated nanoparticles on metabolically engineered mesenchymal stem cells. Seungho Lim, Woojun Kim, Sukyung Song, Man Kyu Shim, Hong Yeol Yoon, Byung-Soo Kim, Ick Chan Kwon*, Kwangmeyung Kim. Bioconjugate Chemistry 2021, 32, 199-214.
8. Han Young Kim, Sang Hoon Um, Yejin Sung, Man Kyu Shim, Suah Yang, Jooho Park, Eun Sun Kim, Kwangmeyung Kim, Ick Chan Kwon*, Ju Hee Ryu. Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug. Journal of Controlled Release 328, 222-236, December 2020.
9. Yongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, Suah Yang, Jaewan Lee, Ji Woong Choi, Yujeong Moon, Jinseong Kim, Seungho Lim, Man Kyu Shim, Sangmin Jeon, Ick Chan Kwon*, Kwangmeyung Kim. Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death. Pharmaceutics 12, 1165, December 2020.
10. Ju Hee Ryu, Hong Yeol Yoon, In‐Cheol Sun, Ick Chan Kwon*, Kwangmeyung Kim. Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity. Advanced Materials 32, 2002197, December 2020.
11. Yongwhan Choi, Hyounkoo Han, Sangmin Jeon, Hong Yeol Yoon, Hyuncheol Kim, Ick Chan Kwon*, Kwangmeyung Kim. Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound. Pharmaceutics 12, 974, October 2020.
12. Young Ji Ko, Jong Won Lee, Hyosuk Kim, EunJi Cho, Yoosoo Yang, In-San Kim, Sun Hwa Kim, Ick Chan Kwon*. Versatile activatable vSIRPα-probe for cancer-targeted imaging and macrophage-mediated phagocytosis of cancer cells. Journal of Controlled Release 323,376-386, July 2020.
13. Gi Beom Kim, Gi-Hoon Nam, Yeonsun Hong, Jiwan Woo, Yakdol Cho, Ick Chan Kwon, Yoosoo Yang, In-San Kim. Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. Science Advances 2, eaaz2083, July 2020.
14. Jiwon Kim, Hee Jeong Jang, Dawid Schellingerhout, Jeong Wook Kang, Seungbum Choi, Hyerin Oh, Eo Jin Kim, Su-Kyoung Lee, Ji Sung Lee, Ick Chan Kwon, Kwangmeyung Kim, Young Jun Koh, Wi-Sun Ryu, Dong-Eog Kim. Effects of exercise training and detraining on atheromatous matrix metalloproteinase activity in mice. Atherosclerosis 299, 15023, April 2020.
15. Min Ju Kim, So Jin Lee, Ju Hee Ryu, Sun Hwa Kim, Ick Chan Kwon*, Thomas M Roberts. Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment. Journal of Controlled Release 318, 98-108, February 2020.
16. Sun Young Wang, Hyosuk Kim, Gijung Kwak, Sung Duk Jo, Daeho Cho, Yoosoo Yang, Ick Chan Kwon, Ji Hoon Jeong, Sun Hwa Kim. Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds. Theranostics 10, 3240, January 2020.
17. Manse Kim, Abhishek Sahu, Youngmin Hwang, Gi Beom Kim, Gi Hoon Nam, In-San Kim, Ick Chan Kwon*, Giyoong Tae. Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E−/-mice. Biomaterials 226, 119550, January 2020.
18. Young Ji Ko, Jae-Won Lee, Eun-Jeong Yang, Nayoon Jang, Jooho Park, Yoon Kyung Jeon, Je-Wook Yu, Nam-Hyuk Cho, Hye-Sun Kim, Ick Chan Kwon*. Non-invasive in vivo imaging of caspase-1 activation enables rapid and spatiotemporal detection of acute and chronic inflammatory disorders. Biomaterials 226, 119534, January 2020.

[Keiichi MOTOYAMA & Taishi HIGASHI]

1. Masamichi Inoue, Hirofumi Jono, Takashi Saito, Risako Onodera, Taishi Higashi, Keiichi Motoyama, Feasibility Study of shRNA Polyplex as a Multi-functional Drug for Alzheimer's Disease, JSB/SFB Joint Symposium (online), Hawaii, USA, January 8-10 (2022).
2. Kosei Utatsu, Tetsuya Kogo, Toru Taharabaru, Risako Onodera, Keiichi Motoyama, Taishi Higashi, Transformable Supramolecular Materials for Reversible PEGylation of Protein Drugs, JSB/SFB Joint Symposium (online), Hawaii, USA, January 8-10 (2022).
3. Takaya Ariyoshi, Masamichi Inoue, Risako Onodera, Taishi Higashi, Keiichi Motoyama. Cationic Dendrimer as a Novel Melanogenesis Inhibitor, JSB/SFB Joint Symposium (online), Hawaii, USA, January 8-10 (2022).
4. Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery. R. Yokoyama, T. Taharabaru, T. Nishida, Y. Ohno, Y. Maeda, M. Sato, K. Ishikura, K. Yanagihara, H. Takagi, T. Nakamura, S. Ito, S. Ohtsuki, H. Arima, R. Onodera, Higashi, K. Motoyama, J. Control. Release, 328, 722-735 (2020).
5. Improvement of pharmaceutical properties of Zerumbone, a multifunctional compound, using cyclodextrin derivatives. Md. M. Hassan, A.F.A. Mohammed, K.M. Elamin, H.P. Devkota, Y. Ohno, Motoyama, T. Higashi, T. Imai, Chem. Pharm. Bull., 68, 1117-1120 (2020).
6. Efficient anticancer drug delivery for pancreatic cancer treatment utilizing supramolecular polyethylene-glycosylated bromelain. Higashi, T. Kogo, N. Sato, T. Hirotsu, S. Misumi, H. Nakamura, D. Iohara, R. Onodera, K. Motoyama, H. Arima, ACS Appl. Bio Mater., 3, 3005-3014 (2020).
7. Folate-appended cyclodextrin improves the intratumoral accumulation of existing boron compounds. Y. Matsumoto, K. Hattori, H. Arima, Motoyama, T. Higashi, H. Ishikawa, N. Fukumitsu, T. Aihara, K. Nakai, H. Kumada, H. Sakurai, Appl. Radiat. Isot., 163, 109201 (2020).
8. Genome editing in a wide area of the brain using dendrimer-based ternary polyplexes of Cas9 ribonucleoprotein. T. Taharabaru, R. Yokoyama, Higashi, A.F.A. Mohammed, M. Inoue, Y. Maeda, T. Niidome, R. Onodera, K. Motoyama, ACS Appl. Mater. Interfaces, 12, 21386-21397 (2020).
9. Differential effects of 2-hydroxypropyl-cyclodextrins on lipid accumulation in Npc1-null cells. S. Hoque, Y. Kondo, N. Sakata, Y. Yamada, M. Fukaura, Higashi, K. Motoyama, H. Arima, K. Higaki, A. Hayashi, T. Komiya, Y. Ishitsuka, T. Irie, Int. J. Mol. Sci., 21, 898 (2020).
10. Nanoparticle drug delivery systems for α-mangostin. N. Wathoni, A. Rusdin, Motoyama, I.M. Joni, R. Lesmana, M. Muchtaridi, Nanotechnol. Sci. Appl., 13, 23-36 (2020).
11. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer. R. Lee, Y.J Choi, M.y.S Jeong, Y.Il. Park, Motoyama, M.W. Kim, S.H. Kwon, J.H. Choi, Bioconjug. Chem., 31, 923-932 (2020).
12. A thermoresponsive hydrophobically modified hydroxypropylmethyl cellulose/cyclodextrin injectable hydrogel for the sustained release of drugs. M. Okubo, D. Iohara, M. Anraku, Higashi, K. Uekama, F. Hirayama, Int. J. Pharm., 575, 118845 (2020).